Batra Yogesh, Pal Sujoy, Dutta Usha, Desai Premal, Garg Pramod Kumar, Makharia Govind, Ahuja Vineet, Pande Girish Kumar, Sahni Peush, Chattopadhyay T K, Tandon Rakesh Kumar
Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi 110-029, India.
J Gastroenterol Hepatol. 2005 Feb;20(2):309-14. doi: 10.1111/j.1440-1746.2005.03576.x.
Gallbladder cancer (GBC) is one of the most common gastrointestinal malignancies. The data regarding GBC are, however, limited.
Records of 634 patients with GBC over a 10-year period were examined with regard to the clinical presentation, investigative findings, treatment, operative findings and outcome.
The mean age of patients was 51 +/- 11 years and men : women ratio was 0.36:1.00. Pain, jaundice and hepatomegaly were seen in 81.0%, 76.0% and 61.5% patients, respectively. On imaging, a mass replacing the gallbladder was seen in 73% patients. Gallstones were present in 54% patients. Surgery was carried out in 291 (46%) patients and endoscopic treatment in 72 (19%) patients but no intervention was carried out in the remaining patients because of disseminated disease. Among the patients who were operated on, 2.0% had stage I GBC, 3.4% stage II, 17.5% stage III, 47.0% stage IVa and 29.8% stage IVb. Radical resection was possible in 133 (46%) patients. The 30-day mortality was 10% with most (90%) deaths in patients with stage IV disease. The median survival after simple cholecystectomy and radical surgery was 33.5 and 12.0 months, respectively. However, among those who underwent debulking, palliative bypass or exploratory laparotomy alone, the survival ranged between 1 and 3 months. Logistic regression analysis showed that only radical resection improved the long-term survival (P < 0.05).
The majority of patients with GBC in India have advanced unresectable disease. Detection of GBC at an early stage is incidental and rare but is associated with long-term survival. Radical surgery, when feasible, is the only option for achieving long-term survival.
胆囊癌(GBC)是最常见的胃肠道恶性肿瘤之一。然而,关于胆囊癌的数据有限。
对634例胆囊癌患者10年间的记录进行了检查,内容包括临床表现、检查结果、治疗情况、手术所见及预后。
患者的平均年龄为51±11岁,男女比例为0.36:1.00。分别有81.0%、76.0%和61.5%的患者出现疼痛、黄疸和肝肿大。影像学检查显示,73%的患者胆囊被肿块取代。54%的患者存在胆结石。291例(46%)患者接受了手术,72例(19%)患者接受了内镜治疗,但其余患者因疾病播散未进行任何干预。在接受手术的患者中,2.0%为Ⅰ期胆囊癌,3.4%为Ⅱ期,17.5%为Ⅲ期,47.0%为Ⅳa期,29.8%为Ⅳb期。133例(46%)患者可行根治性切除。30天死亡率为10%,大多数(90%)死亡发生在Ⅳ期疾病患者中。单纯胆囊切除术后和根治性手术后的中位生存期分别为33.5个月和12.0个月。然而,在仅接受减瘤手术、姑息性旁路手术或剖腹探查术的患者中,生存期为1至3个月。逻辑回归分析表明,只有根治性切除能提高长期生存率(P<0.05)。
印度大多数胆囊癌患者患有晚期不可切除疾病。胆囊癌的早期发现偶然且罕见,但与长期生存相关。可行时,根治性手术是实现长期生存的唯一选择。